LabTurbo Biotech Corporation (7725) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for LabTurbo Biotech Corporation (7725:TWSE), powered by AI.

Current Price
$22.60
P/E Ratio
83.8
Market Cap
1.1B
Sector
Healthcare
What is the LabTurbo Biotech Corporation stock price forecast?

LabTurbo Biotech Corporation is currently trading at $22.60. View real-time AI analysis on Alpha Lenz.

What is LabTurbo Biotech Corporation insider trading activity?

View the latest insider trading data for LabTurbo Biotech Corporation on Alpha Lenz.

What is LabTurbo Biotech Corporation's P/E ratio?

LabTurbo Biotech Corporation's P/E ratio is 83.8.

LabTurbo Biotech Corporation

TWSE · 7725
NT$22.60-0.20(-0.88%)
Ask about LabTurbo Biotech Corporation's future dividend policy...
Alpha Chat Insight

LabTurbo Biotech Corporation trades at a P/E of 83.8 (premium valuation) with modest ROE of 1.0%.

Ask for details

Company Overview

LabTurbo Biotech Corporation is a biotechnology company specializing in the research, development, and manufacturing of fully automated precision medical genetic testing systems and reagent kits. Established in 2000 and headquartered in Taipei, Taiwan, the company provides advanced solutions for nucleic acid extraction and molecular diagnostic testing, serving hospitals and clinical laboratories across Taiwan, the United States, Europe, the Middle East, and Southeast Asia. Its core product line, including the LabTurbo AIO and QuadAIO systems, offers high-throughput, automated genetic testing designed to improve the accuracy, speed, and standardization of diagnostic workflows. LabTurbo is recognized for its innovative approach to precision diagnostics, holding numerous international patents and having received national awards for innovation and research. The company’s technology supports applications in infectious disease detection, genetic screening, and precision medicine, reflecting its pivotal role in modern healthcare diagnostics and the global expansion of molecular testing capabilities.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2024

Profile

NT$1.09BMarket Cap
NT$72.97MRevenue
0.00Shares Out
0Employees

Margins

23.33%Gross
78.92%EBITDA
-250.10%Operating
10.59%Pre-Tax
17.76%Net

Valuation

83.76P/E
0.83P/B
14.88EV/Sales
16.29EV/EBITDA
-7.73P/FCF

Growth (CAGR)

-57.92%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
-69.54%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

0.93%ROA
0.98%ROE
0.59%ROIC

Financial Health

NT$175.62MCash & Cash Equivalents
NT$-99.49MNet Debt
5.80%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

LabTurbo Biotech Corporation (ticker: 7725) is a company listed on TWSE in the Healthcare sector (Biotechnology). Market cap is $1.1B.

The current price is 22.6 with a P/E ratio of 83.76x and P/B of 0.83x.

ROE is 0.98% and operating margin is -250.10%. Annual revenue is $73M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
LabTurbo Biotech Corporation (7725) Stock Forecast 2026 $22.60 — Price, Financials & Analyst Targets | Alpha Lenz